ABVX.PA ABIVAX | FR0012333284
Financials
Trends
Details
| Breakdown | 31.12.2027 | 31.12.2026 | Change % |
|---|---|---|---|
| Total Revenue | 82.734.340 | 74.922.880 | 10.43% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Operating Expense | -- | -- | -- |
| Selling General and Administrative | -- | -- | -- |
| Research & Development | -- | -- | -- |
| Operating Income | -- | -- | -- |
| Pretax Income | -- | -- | -- |
| Net Income Common Stockholders | -- | -- | -- |
| Basic EPS | -2,64 | -3,82 | 30.75% |
| Diluted EPS | -- | -- | -- |
| Analyst Count | 3 | 4 | 25.00% |
| EBIT | -- | -- | -- |
| EBITDA | -- | -- | -- |